Ramucirumab with cisplatin and fluoropyrimidine as first-line therapy in patients with metastatic gastric or junctional adenocarcinoma (RAINFALL): a double-blind, randomised, placebo-controlled, phase 3 trial

Charles S. Fuchs, Francesco Di Costanzo, Fidel David Huitzil Melendez et al.|The Lancet Oncology|2019

Cited by 282